ACTH-cortisol pathway

London, United Kingdom, September 13, 2026 GSK has announced positive Phase III ARTEMIS-008 results showing that its investigational risvutatug...

Arlington, Massachusetts, U.S., September 11, 2026 Eloxx Pharmaceuticals has announced that the first two patients have been dosed in...

Copenhagen, Denmark, September 10, 2026 H. Lundbeck A/S has announced that the U.S. Food and Drug Administration (FDA) has...